UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma

Journal of vascular and interventional radiology, 2016-06, Vol.27 (6), p.795-802

2016

Volltextzugriff (PDF)

Systemic Treatment Options for Carcinoid Syndrome: A Systematic Review

Oncology, 2019-06, Vol.96 (6), p.273-289

2019

Volltextzugriff (PDF)

Real-world treatment patterns of gastrointestinal neuroendocrine tumors: A claims database analysis

World journal of gastroenterology : WJG, 2017-09, Vol.23 (33), p.6128-6136

2017

Volltextzugriff (PDF)

An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)

Oncology, 2018-01, Vol.94 (1), p.39-46

2018

Volltextzugriff (PDF)

Real-World Treatment Patterns for Lung Neuroendocrine Tumors: A Claims Database Analysis

Oncology, 2018-04, Vol.94 (5), p.281-288

2018

Volltextzugriff (PDF)

Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and Survival

Journal of vascular and interventional radiology, 2016-09, Vol.27 (9), p.1279-1287

2016

Volltextzugriff (PDF)

Disparities in gastrointestinal cancers

Journal of the National Medical Association, 2023-05, Vol.115 (2), p.S13-S18

2023

Volltextzugriff (PDF)

Treatment adherence, healthcare resource utilization, and costs in patients with lung neuroendocrine tumors (lung NETs) in the USA

Current medical research and opinion, 2018-12, Vol.34 (12), p.2151-2156

2018

Volltextzugriff (PDF)

Gemcitabine remains the standard of care for pancreatic cancer

Nature reviews. Clinical oncology, 2010-03, Vol.7 (3), p.135-137

2010

Volltextzugriff (PDF)

Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumors

Cancer treatment reviews, 2013-02, Vol.39 (1), p.27-43

2013

Volltextzugriff (PDF)

Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1498-1504

2003

Volltextzugriff (PDF)

An update on pharmacotherapies for colorectal cancer: 2023 and beyond

Expert opinion on pharmacotherapy, 2024, Vol.25 (1), p.91-99

2024

Volltextzugriff (PDF)

Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297

Journal of clinical oncology, 2002-08, Vol.20 (15), p.3270-3275

2002

Volltextzugriff (PDF)

Have the changes in treatment of rectal cancer made a significant difference to our patients?

Oncology (Williston Park, N.Y.), 2011-12, Vol.25 (14), p.1323-1329

2011

Volltextzugriff (PDF)

Bevacizumab in the treatment of colorectal cancer

Expert opinion on biological therapy, 2005-07, Vol.5 (7), p.997-1005

2005

Volltextzugriff (PDF)

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2017-06, Vol.317 (23), p.2392

2017

Volltextzugriff (PDF)

Gastrointestinal Malignancies

1, 2016

Volltextzugriff (PDF)

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma

Journal of surgical oncology, 2010-06, Vol.101 (7), p.587-592

2010

Volltextzugriff (PDF)

Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement

Journal of clinical oncology, 2013-12, Vol.31 (35), p.4465-4470

2013

Volltextzugriff (PDF)

Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort

JAMA network open, 2024-01, Vol.7 (1), p.e2351700-e2351700

2024

Volltextzugriff (PDF)

TREATMENT OF GASTRIC CANCER FOR SURVIVAL-STRATEGIES IN THE USA AND JAPAN

Annals of Cancer Research and Therapy, 2003, Vol.11(1-2), pp.15-30

2003

Volltextzugriff (PDF)

Radioembolization of colorectal hepatic metastases using yttrium‐90 microspheres

Cancer, 2009-05, Vol.115 (9), p.1849-1858

2009

Volltextzugriff (PDF)

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

Journal of clinical oncology, 2011-11, Vol.29 (31), p.4105-4112

2011

Volltextzugriff (PDF)

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

Journal of clinical oncology, 2012-12, Vol.30 (35), p.4344-4351

2012

Volltextzugriff (PDF)

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology

Archives of pathology & laboratory medicine (1976), 2016-12, Vol.140 (12), p.1345-1363

2016

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(111)
Buchkapitel
(17)
Bücher
(2)

Sprache

Englisch
(130)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(96)
Science & Technology
(96)
Humans
(90)
Oncology
(77)
Biological And Medical Sciences
(63)
Medical Sciences
(62)
Female
(59)
Male
(56)
Middle Aged
(47)
Tumors
(45)
Aged
(40)
Adult
(36)
Gastroenterology. Liver. Pancreas. Abdomen
(31)
Treatment Outcome
(31)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(27)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(26)
Antineoplastic Agents
(24)
Chemotherapy
(24)
Pharmacology. Drug Treatments
(24)
Fluorouracil - Administration & Dosage
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma

Systemic Treatment Options for Carcinoid Syndrome: A Systematic Review

Real-world treatment patterns of gastrointestinal neuroendocrine tumors: A claims database analysis

An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)

Real-World Treatment Patterns for Lung Neuroendocrine Tumors: A Claims Database Analysis

Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and Survival

Disparities in gastrointestinal cancers

Treatment adherence, healthcare resource utilization, and costs in patients with lung neuroendocrine tumors (lung NETs) in the USA

Gemcitabine remains the standard of care for pancreatic cancer

Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumors

Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer

An update on pharmacotherapies for colorectal cancer: 2023 and beyond

Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297

Have the changes in treatment of rectal cancer made a significant difference to our patients?

Bevacizumab in the treatment of colorectal cancer

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

Gastrointestinal Malignancies

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma

Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement

Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort

TREATMENT OF GASTRIC CANCER FOR SURVIVAL-STRATEGIES IN THE USA AND JAPAN

Radioembolization of colorectal hepatic metastases using yttrium‐90 microspheres

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology

Suchergebnisse filtern